Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.
- DOI
- 10.1007/s10147-025-02858-3
- Published
- 2025 Nov
- Container
- International journal of clinical oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-025-02858-3,
title = {Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.},
author = {Suzuki K and Miyake H and Inaki A and Takano S and Kuboki Y and Mizowaki T and Nakamura K and Ueno M and Matsumoto S and Obinata D and Nakagawa T and Murakami M and Majima Y and Yokono M and Namba M and Yoshino T},
year = {2025},
journal = {International journal of clinical oncology},
doi = {10.1007/s10147-025-02858-3},
url = {https://doi.org/10.1007/s10147-025-02858-3}
}RIS
TY - JOUR TI - Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology. AU - Suzuki K AU - Miyake H AU - Inaki A AU - Takano S AU - Kuboki Y AU - Mizowaki T AU - Nakamura K AU - Ueno M AU - Matsumoto S AU - Obinata D AU - Nakagawa T AU - Murakami M AU - Majima Y AU - Yokono M AU - Namba M AU - Yoshino T PY - 2025 JO - International journal of clinical oncology DO - 10.1007/s10147-025-02858-3 UR - https://doi.org/10.1007/s10147-025-02858-3 ER -
APA
K, S., H, M., A, I., S, T., Y, K., T, M., K, N., M, U., S, M., D, O., T, N., M, M., Y, M., M, Y., M, N., & T, Y. (2025). Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology.. International journal of clinical oncology. https://doi.org/10.1007/s10147-025-02858-3
Source records
- pubmed · retrieved 2026-09-26T07:39:08.067Z